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INTRODUCTION
Acute lower respiratory tract infections (LRTIs) are the leading cause of childhood mortality and morbidity, particularly in the developing world. Viruses are the most frequent cause of acute respiratory infections and respiratory syncytial virus (RSV) is the main viral agent causing pediatric LRTIs worldwide. [1, 2] Diagnosis is impossible on clinical grounds alone as the presentation is indistinguishable from other respiratory tract infections and epidemics often overlap. The specific diagnosis of RSV infection is based on the detection of virus or viral antigens or virus-specific nucleic acid sequences in respiratory secretions. Rapid detection of RSV is useful in guiding immediate treatment and minimizing antibiotic overuse. [3] The present study was undertaken to evaluate the role of RSV in etiology of acute community-acquired LRTIs in children aged <2 years by employing chromatographic immunoassay to detect RSV antigen in nasopharyngeal aspirates.
MATERIALS AND METHODS
This prospective cross-sectional study included 85 children <2 years of age presented with acute LRTIs and admitted to the Department of Pediatrics of a tertiary care health facility in New Delhi, India, from February 2011 to March 2012.
DISCUSSION
RSV is the primary viral etiological agent causing pediatric LRTIs. The peak incidence of RSV-associated LRTIs, severe LRTIs, and RSV-associated hospitalizations is reported in infants <6 months of age. [4] Fattouh et al. have reported 64% RSV-positive patients in their study to be <6 months of age. [5] We also report similar findings with 32 (60.4%) RSV-positive patients in our study belonging to this age group. However, numerically, RSV positivity was comparable in both males and females in our study; some studies have documented a male preponderance of RSV infection while others have suggested a difference in disease severity, with males being more susceptible to severe RSV disease than females. [6] The clinical manifestations of RSV LRTIs are difficult to distinguish from other forms of viral or bacterial LRTIs due to significant overlap of signs and symptoms with no pathognomic finding. [7] In our study also, no statistically significant correlation could be established between clinical characteristics and RSV infection. Radiological manifestations of RSV infection are reportedly nonspecific and differ in different studies. Kern et al. have reported central pneumonia (32%) and normal X-ray chest (30%) as the most common radiological features in RSV-induced LRTIs. [8] We observed a normal chest radiograph in a majority of RSV-positive patients, and differentiation of RSV-positive and RSV-negative groups on the basis of radiological features was not possible.
In the present study, RSV was detected in 53 (62.4%) children by detecting the RSV fusion protein, employing a chromatographic immunoassay. Employing multiple diagnostic modalities, the reported incidence of RSV LRTIs in Indian pediatric population has varied from 22.1% to 46.6% in various studies. [9, 10] In another study, respiratory RSV was detected in 61 (20.3%) of 301 nasopharyngeal aspirates employing multiplex polymerase chain reaction. [11] We report a very high incidence of 62.4% of RSV-associated LRTIs in our study group. A possible explanation is that different studies have employed different inclusion criteria leading to different incidence of RSV infection. In our study, we exclusively included children aged <2 years (age group most commonly affected by RSV), while other studies where older children up to 5 years of age were included have reported a lower incidence of RSV infection. Moreover, our study was conducted on a wider range of LRTIs including bronchiolitis, wheeze-associated LRTIs, and pneumonia.
Chromatographic immunoassays, though less sensitive and specific than other diagnostic modalities such as direct fluorescent antibody staining, are more user-friendly and do not demand technical time and expertise. These single-step methods serve as "walk away" tests requiring no addition of reagents. They are rapid, reliable, and easy to perform and interpret. Early detection of RSV by these chromatographic immunoassays allows cohorts of infected inpatients to prevent nosocomial transmission of RSV and consideration of appropriate treatment by avoiding unnecessary use of antibiotics. This assay, however, has some limitations: it detects both viable and nonviable RSV particles and inadequate specimen collection, improper handling/transport, or low levels of virus shedding may yield a false-negative result.
CONCLUSION
Our data underline that chromatographic immunoassays are valuable diagnostic techniques for rapid identification of RSV in pediatric LRTIs.
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INTRODUCTION
Pindborg tumor, also known as calcifying epithelial odontogenic tumor (CEOT), is a rare and unusual epithelial benign odontogenic neoplasm, accounts for 1% of all odontogenic tumors. This neoplasm affects individuals in fourth-to-fifth decades of life and shows no gender predilection. Clinically presents as a slow-growing, painless expansile hard bony swelling, associated mostly with an impacted tooth in the posterior mandibular region. [1] The etiology of this tumor is disputatious. Literature reveals that it arises from the epithelial remnants from enamel organ, but whether reduced enamel epithelium, stratum intermedium, or dental lamina remnants are involved in the etiology still remains an enigma. [2] CEOT, according to the clinical presentation and histopathology is differentiated as central or intraosseous (87.8%), peripheral or extraosseous (6.1%), or as a hybrid tumor in combination with adenomatoid odontogenic tumor (AOT). This neoplasm has the tendency to recur, as recurrence occurs in 15% of the cases. [3] 
CASE REPORT
A 22-year-old male presented with a chief complaint of swelling in the lower left posterior region for 5-6 months. On examination, intraorally, a small swelling in the left retromolar area was observed [ Figure 1a ]. On palpation, the swelling was firm in consistency and nontender. Radiographically, a well-defined radiolucency was seen on the left side, extending from 35 to 38 region anteroposteriorly and from the alveolar crest to inferior border of the mandible involving inferior alveolar nerve canal. The inferior border of the mandible appears to be intact and continuous, 36 remains to be supraerupted and 37 is displaced to the inferior border of the ramus [ Figure 1b ]. The provisional diagnosis was ameloblastoma, AOT, and dentigerous cyst. An incisional biopsy was performed and the histopathological report revealed sheets and cords of polyhedral epithelial cells with abundant eosinophilic cytoplasm. The cellular outlines were distinct with prominent intercellular bridges. Nuclei were large and hyperchromatic. Areas of extracellular, eosinophilic, and amyloid-like material with occasional concentric calcifications called as Liesegang rings were also evident [ Figure 2a and b]. Congo red stain showed apple-green birefringence under polarized microscopy [ Figure 2c ] and modified Gallegos stain, which stained red for the calcifications when seen under microscope [ Figure 2d ]. On the basis of histopathological report, the final diagnosis given was CEOT.
DISCUSSION
The Pindborg tumor (CEOT) was first reported by Pindborg in 1955, also referred as unusual ameloblastoma by Tuy, cystic odontoma by Stoppack, and Adenoid adamantoblastoma by Thoma. [2] Although the etiology remains uncertain, literature suggests that the epithelial cells of Pindborg tumor are remnants of sequestered material in the stratum intermedium layer of the enamel organ. This is based on the ideology that the tumor cells are morphologically similar to the cells of stratum intermedium and shows a high activity of alkaline phosphatase and adenosine triphosphate. Literature also states that the amyloid deposits within the Pindborg tumor are an immunologic response to these stratum intermedium cells. Some authors state that it arises from the remnants of dental lamina which are more likely to be the true progenitor cell. [4] Our case was rare as it was observed in the second decade of life, compared with the age listed in literature, as most of the cases occurred with the mean age of 40 years. [5] Pindborg reported 2 clinicopathological variants: intraosseous (central) and extraosseous variant (peripheral) with an incidence of 96% and 4%, respectively. According to his observations, the central tumors are derived from stratum intermedium of enamel organ in comparison to the extraosseous form which arises from the dental lamina. [6] Histopathologically, CEOT consists of large sheets, islands, cords, rows, and strands of polyhedral epithelial cells with a scanty connective tissue stroma. The cells show distinct cellular outline, with prominent intercellular bridges and abundant eosinophilic granular cytoplasm. Moderate degree of pleomorphism and rare atypical mitosis may be noticed in these neoplastic cells. These neoplastic cells show centrally located pleomorphic, hyperchromatic, and bizarre nuclei, which often show large nucleolus. The characteristic findings of this tumor are the presence of rounded pale, eosinophilic amyloid-like masses within the sheets of tumor cells. Because of its affinity with mineral salt, this material can undergo calcification leading to the concentric lamellar bodies termed as Liesegang rings. Large pools of homogeneous eosinophilic material may be noticed in the surrounding tissue along with diffusely deposited calcium salts in some areas. This amyloid-like material appears as an apple-green birefringence under polarized microscope when stained with Congo red. [2, 7] Several variants of this tumor are the clear cells, Langerhans cells, bone and cementum-like component, and myoepithelial cells. Combined lesions of CEOT with ameloblastoma and AOT are also documented in literature. [8] The present case showed characteristic histopathologic features of CEOT, such as large sheets and islands composed of epithelial cells with a scanty, loose fibrous connective tissue stroma. The epithelial sheets were composed of polyhedral tumor cells with an eosinophilic cytoplasm with large dense hyperchromatic nuclei. The epithelial cells were compactly arranged and showed intercellular bridges. The homogeneous eosinophilic globular masses were observed majorly in the epithelium resulting in a cribriform appearance. Liesegang's rings were also evident. Various researchers analyzed the amyloid material and stated that its derivation still remains a mystery like its etiology. These studies conclude that a degenerative process involving cytokeratin intermediate filaments in tumor cells is responsible for amyloid degeneration, while others concluded that it involves degeneration of type IV collagen associated with basement membrane. [8, 9] The present case, when subjected to Congo red stain, amyloid deposits appeared as bright orange-to-red hue, while when exposed to polarize light, it demonstrated birefringence to distinctive green-yellow color described as apple green. In addition, we performed modified Gallegos stain, which differentiates histochemically hard tissue structures of the oral cavity, in which the enamel stains pink, dentine and bone stains green, and cementum stains red. [10] In our case, we found that amyloid-stained pink, while the calcifications and Liesegang's rings stained pinkish blue. This is in favor of various theories put forward by the researchers in the literature that the amyloid derives from the epithelial cells of the odontogenic apparatus. [8] 
CONCLUSION
CEOT is a rare benign odontogenic tumor. The diagnosis of which can be confirmed by its classic histopathological features. However, the exact nature of the tumor and the pathogenesis is obscure till date.
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ABSTRACT
A 58-year-old female, a known diabetic and hypertensive, presented with left-sided swelling on the anterior aspect of the neck of 1-year duration, which was rapidly increasing in size for the past 6 months. She was on Eltroxin for hypothyroidism for the past 1 year. Computed tomography study of the neck showed a nodule in the left lobe of thyroid which on fine-needle aspiration was suspicious for malignancy. Total thyroidectomy with left posterolateral lymph node dissection was done. Histopathological examination showed sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) of the thyroid gland with lymph node metastasis. SMECE of the thyroid was initially thought to be a low-grade malignancy with indolent clinical behavior. However, our case showed extra thyroidal spread with lymph node metastasis, necessitating adjuvant therapy for our patient. Such aggressive behavior has been noted in few earlier case reports also.
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INTRODUCTION
Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) of the thyroid was first described by Chan et al. in 1991. [1] It is characterized by nests or strands of epidermoid neoplastic cells with squamous differentiation and areas of glandular differentiation with rare mucous cells in a prominent sclerotic stroma with dense eosinophilic and lymphocytic infiltration. Almost all these cases are associated with chronic lymphocytic (Hashimoto) thyroiditis. This is a distinct entity which has to be differentiated from mucoepidermoid carcinoma of the thyroid as well as other thyroid malignancies which can show squamous differentiation such as papillary carcinoma, medullary carcinoma, and anaplastic carcinoma. Primary squamous cell carcinoma of thyroid though rare and squamous cell carcinoma of adjacent structures infiltrating thyroid should also be considered in the differential diagnosis. However, the distinct squamous cell nests including keratinized ones, glandular pattern, and mucus cells with characteristic sclerotic stroma with the background showing eosinophils are diagnostic. Like other thyroid disorders, this entity is also more common in females. However, there are few case reports in the literature, wherein SMECE occurred in male patients.
CASE REPORT
A 58-year-old female who was a known diabetic and hypertensive on medication presented to our outpatient clinic with complaints of swelling in the anterior aspect of the neck. She was on tablet Eltroxin for hypothyroidism for the past 1 year. She gave a history of swelling anterior aspect of the neck for the past 1 year, which was increasing in size for the past 6 months with associated difficulty in deglutition. On examination, there was a firm-to-hard mass on the anterior aspect of the neck more towards the left, moving with deglutition.
Computed tomography (CT) neck s h o w e d a n o d u l e m e a s u r i n g 4.8 cm × 2.5 cm × 2.3 cm in the left lobe of thyroid displacing trachea to the right of midline, with tracheoesophageal groove extension. Left level III lymph node measuring 25 mm × 15 mm × 13 mm and left paratracheal node measuring 8 mm × 6 mm were also picked up in CT. Nasopharyngeal laryngoscopy showed left vocal cord palsy and mucosal bulge in SMECE is almost exclusively seen in women and is usually associated with lymphocytic thyroiditis. However, very few case reports of this entity in male patients have also been reported. [2] The SMECE of thyroid gland most commonly presents as painless neck mass or cold nodule on thyroid scan. Nonspecific symptoms such as hoarseness of voice and difficulty in deglutition occur depending on extension of tumor and compression or infiltration of adjacent structures. The histogenesis of these tumors was a matter of controversy with some authors suggesting that these tumors develop from ultimobranchial body rests/solid cell nests, others reported a follicular origin. Few authors also suggested an origin from C-cells, parathyroid, ectopic salivary gland, and thyroglossal duct. [3, 4] However, another concept is that these tumors arise from follicular epithelium-derived metaplastic squamous nests that occur in a setting of Hashimoto or lymphocytic thyroiditis. [5, 6] However, recent molecular analysis study by Shah et al. on nine cases of SMECE showed cases to be negative for mutations and translocations commonly involved in thyroid carcinogenesis. Their study also showed negativity for MAML2 translocation which is usually positive in mucoepidermoid carcinoma of the salivary gland. Thus, Shah et al. concluded that SMECE appears molecularly and morphologically distinct from follicular and C-cell-derived thyroid tumors as well as from salivary gland mucoepidermoid carcinoma. [7] trachea. Fine-needle aspiration was done which was reported as suspicious for malignancy. The patient was taken up for surgery.
Per-operatively, there was a 5 cm × 3 cm nodule involving the entire left lobe with extension into tracheoesophageal groove. Right lobe and isthmus appeared normal. Total thyroidectomy with left posterolateral neck dissection was done. The tumor had to be shaved off from the esophagus and only an R1 resection could be achieved. Gross specimen that we received showed thyroidectomy specimen with an enlarged left lobe. On cut section, there was a firm-to-hard gray-white growth measuring 5 cm × 3 cm involving entire left lobe with the involvement of thyroid capsule [ Figure 1 ]. Right lobe and isthmus appeared normal.
Microscopy showed a neoplasm composed of small irregular nests and anatomizing strands of epidermoid cells and glandular structures in a sclerotic stroma with the background showing dense eosinophilic infiltration along with lymphocytes and plasma cells [ Figure 2a ]. Well-formed squamous pearls were also noted [ Figure 2b ]. Interspersed with the epidermoid cell nests were noted mucous secreting cells and small mucin pools [ Figure 2c ]. The cells lining the glandular spaces showed moderate amount of clear/eosinophilic cytoplasm and vesicular nucleus. The neoplasm was seen to infiltrate the thyroid capsule with extrathyroidal spread. Left level III node showed metastasis. The metastatic component comprised predominantly of epidermoid cells in nests and cords with dense eosinophilic infiltration [ Figure 2d ]. Immunohistochemistry (IHC) showed positive staining with thyroglobulin and thyroid transcription factor-1 (TTF-1) in both epidermoid and glandular areas [ Figures 3a and b ]. However, the positivity for these antibodies in epidermoid areas were much weaker as compared to the glandular areas. Mucin stain done highlighted intracellular as well as extracellular mucin. A diagnosis of SMECE of thyroid with metastasis to left level III node was given. 
: (a) Microscopy showing nests and anatomizing strands of epidermoid cells and glandular structures in a sclerotic stroma with background showing dense eosinophilic infiltration (H and E, ×200), (b) Section showing well-formed keratin pearls (H and E, ×100), (c) Section showing mucous-secreting cells interspersed with the epidermoid cell nests (H and E, ×200), (d) The metastatic component comprising predominantly of epidermoid cells in nests and cords with dense eosinophilic infiltration (H and E, ×100)
d c b a SMECE should be differentiated from thyroid tumors that can show foci of squamous differentiation and also from the rare primary squamous carcinoma of the thyroid. Thyroid tumorswith areas of squamous differentiation include papillary carcinoma, medullary carcinoma, and anaplastic carcinoma. The dense eosinophilic infiltrate which is characteristic of this entity is, however, absent in all the other conditions. Papillary carcinoma can be differentiated from SMECE by its characteristic nuclear morphology. Medullary carcinoma with areas of squamous and mucinous change, along with its sclerotic amyloid-rich stroma can mimic SMECE. Positive staining with calcitonin in medullary carcinoma will differentiate medullary carcinoma from SMECE. Primary squamous cell carcinoma of thyroid is rare. The morphologically is similar to squamous cell carcinomas of other organs. However, lack of the glandular component as well as background thyroiditis and eosinophilia help in differentiating this from SMECE. The nodal metastasis of SMECE with prominent eosinophils and sclerosis can be mistaken for Hodgkin's lymphoma. [8] IHC in this entity in different case reports showed variable results with thyroglobulin and TTF1, with some studies showing negative staining while some cases showed positive results. [9] In this case, we observed positive staining with thyroglobulin and TTF1 in both epidermoid and glandular areas. However, the positivity for these antibodies in epidermoid areas was much weaker as compared to the glandular areas. Furthermore, SMECE is rather a morphological diagnosis, and IHC is required only when classical features are absent. SMECE of thyroid was initially thought to be a low-grade malignancy with indolent clinical behavior. However, cases with extra thyroidal extension, distant metastasis, and lymph node metastasis have been reported. [9] Early literature shows that in spite of extra thyroidal extension and regional recurrence the survival was good. [10] However, in a recent study by Quiroga-Garza et al. 5 of 6 patients had died within 1.5-8 years after initial diagnosis, 3 of them had distant metastasis, although definite cause of death was not documented. [10, 11] 
CONCLUSION
The behavior of SMECE of thyroid gland may be more aggressive than we thought; and hence, more data regarding follow-up of this rare malignant entity is required for better understanding of this entity. Our patient had an uneventful postoperative period, and considering that only R1 resection was achieved, she is currently being given radiotherapy.
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INTRODUCTION
Clear cell sarcoma (CCS) was first described by Enzinger in 1965. It is a rare, aggressive, soft-tissue tumor constituting approximately 1% of all soft-tissue sarcomas. Due to its close clinical and histological similarity with malignant melanoma, Chung and Enzinger proposed the name "malignant melanoma of soft parts." [1] It is known to occur mainly in the soft tissues and dermis. [2] CCS of tendons and aponeuroses is a rare, high-grade malignant soft-tissue tumor.
CASE REPORT
A 5-year-old boy presented with swelling over the left back for 1 month. The swelling was sudden in onset and gradually progressive in nature. It was very tender and was located 5 cm lateral to the thoracic spine. There was no history of fever. The pain subsided on taking medication. His hematological, coagulation, and biochemical profiles were within normal limits. On examination, the swelling measured 6 cm × 6 cm, was tender and immobile. Clinically, it was diagnosed as an abscess. X-ray revealed a soft-tissue mass with normal underlying bone. Ultrasonography showed a subcutaneous heterogenous collection with internal echoes. Pus was seen in the in the paraspinal ligament of paravertebral region. Peroperatively, it turned out to be solid, giving a clinical impression of sarcoma. Hematoxylin and eosin (H and E)-stained sections of the excised tissue showed the absence of an epithelial covering [ Figure 1a ]. Clusters of fusiform cells [ Figure 1b ] were present that were separated by a thin fibrovascular septa [ Figure 1c ]. The individual cells were large with pleomorphic, vesicular nuclei, prominent 1-2 basophilic nucleoli, and clear cytoplasm [ Figure 1d ]. Mitoses were frequent, approximately 2-3/10 hpf. Apoptotic bodies and areas of necrosis were observed. Few multinucleated giant cells were present. However, no obvious pigmentation could be identified. 
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CCS located in the paraspinal ligament and the fifth affecting the thoracic region. [3] CCS, albeit rare, is generally known to affect the extremities, especially foot and ankle, followed by knee, thigh, and hand. [4] Rare sites of involvement include pleura, chest wall, spinal nerve roots, scapula, retroperitoneum, buttock, and mediastinum. [5, 6] Rarely cases involving kidney, trunk, penis, gastrointestinal tract, and head and neck have also been reported. [7] Majority of the cases of CCS have been observed in the 20-40 age group, with mean age of 27 years [3] and having a predilection for female patients. In this regards, the present case was unique because it presented in a young male child. It originates from tendons, aponeuroses, and fascial structures of the extremities with a predilection for the feet and knees. CCS presents as an insidiously growing lump or hard mass causing pain or tenderness.
CCS is characterized by a recurrent chromosomal translocation t (12; 22), which results in fusion of the EWS gene on 22q with the ATF1 gene on 12q. [8] It has been associated with both EWSR1-ATF1 and EWSR1-CREB1 fusion transcripts. [9] The exact histogenesis remains obscure, but the presence of intracellular melanin in two-third of the cases supports origin from migrated cells of neural crest. [3, 9] For this reason, the term malignant melanoma of soft part seems preferable over the purely descriptive term of CCS. The reciprocal translocation t (12; 22) (q13; q12) is observed in more than 90% of CCS cases along with polysomy of chromosome 8 as a secondary abnormality in many cases. [8, 9] Differentiation of CCS from other close differentials often requires correlation with clinical, histological, and molecular findings. Main differentials include tumors such as metastatic malignant melanoma, malignant cellular blue nevus, malignant peripheral nerve sheath tumor, paraganglioma-like dermal melanocytic tumors and nonmelanotic tumors such as perivascular epithelioid cell tumor (PEComas), epithelioid leiomyosarcoma, fibrosarcoma, alveolar soft-part sarcoma, monophasic synovial sarcoma, and renal cell carcinoma. [1, 10] CCS can involve any ligament, tendon, or aponeurosis. Thus, radiological and histopathological evaluation aided by an appropriate panel of IHC markers is imperative for proper diagnosis. Because of their typical histologic picture and their particular clinical behavior, they should be regarded as a definite clinicopathological entity. Imaging studies such as X-rays, computed tomography (CT) scans or magnetic resonance imaging (MRI) may be required for diagnosis. Chest CT, bone scan, and positron emission tomography are often required to assess metastases. MRI typically shows a benign-looking, well-defined, homogenous mass; on T1-weighted MR images, it is usually homogeneous and isointense or slight hyperintense to muscles, whereas on T2-weighted MR images, it is usually more heterogeneous with variable signal intensity. [4] Diagnosis of CCS can be challenging. Histologically, it shows compact nests or fascicles of predominantly fusiform or spindled cells with a clear to granular cytoplasm surrounded by a delicate framework of fibrocollagenous tissue contiguous with the adjacent tendons or aponeuroses. The cells have highly distinctive features consisting of vesicular nuclei and prominent basophilic nucleoli reminiscent of malignant melanoma. [1] The histologic features of cellular arrangement in nest, cluster or "ball"-like formations and a prominent nucleolus are the most reliable diagnostic patterns. The cytoplasm varies from being clear to weakly eosinophilic and contains a large amount of intracellular glycogen giving it the clear cell appearance. More than 50% of case contains multinucleate (wreath-type) giant cells. Approximately, two-thirds of the tumors contain a variable amount of melanin pigment demonstrable on H and E or, using special stains. The cells show absent or minimal pleomorphism and very few mitotic figures indicating its slow-growing nature. Areas of necrosis may be present. CCS such as melanoma, shows Tumor size more than 5 cm and necrosis are indicators of poor prognosis. Age, location, depth, or proliferation index are independent prognostic factors. Metastasis occurs in more than half of the cases and usually to the bones, lymph node, and lungs with 5-year survival rates of 50%-65%. [3] Recurrence is a common feature. [2] Treatment depends on the site and the extent of the disease. Radical surgery is the mainstay of therapy with chemotherapy used in metastasis. Use of standard sarcoma regimens has not been successful, while interferon-alpha 2 B has been reported to have some role. [10] CONCLUSION CCS should be considered in the differential diagnosis of paraspinal masses. Confirmed diagnosis requires histopathology and IHC marker panel. Complete surgical excision with radiotherapy is the mainstay of treatment.
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INTRODUCTION
Ewing's sarcoma/primitive neuroectodermal tumors (EWS/PNET) are malignant soft-tissue tumors occurring most commonly in the bones in children but increasingly common in the soft-tissues in young adult. Nearly 90% of ES/PNET have a genetic EWS-friend leukemia virus integration-1 (FLI1) fusion protein which results from a specific t (11;22) . The carboxy-terminus of FLI1 in immunochemical stain is sensitive and extremely specific for the diagnosis of ES/PNET. [1] ES/PNET is uncommon in the mesenteric area. It is objectively confirmed by the immunohistochemical stains and molecular analysis. There are only 36 cases of intestinal EWS/PNET have been previously documented and the author has collected all previous cases of a published report of intestinal ES/PNET in Table 1 . Therapeutically, the earlier published cases were almost treated with operation and adjuvant computed tomography (CT), and with elective radiotherapy in some cases.
CASE REPORT
Ms. B is a 25-year-old woman presented to the author's department reporting abdominal tenderness and poor appetite for the past 3 days. She was afebrile and denied any history of the systemic disease or traumatic surgery, and she had well oriented and conscious on general physical examination. Her laboratory tests were all within normal limits, and tumor markers including carcinoembryonic antigen and cancer antigen 19-9 were standard. Abdominal CT showed a homogenous 9 cm × 6 cm mass in the lower abdomen with the invasion of the ileum [ Figure 1a ]. The clinically and radiologically differential diagnoses included gastrointestinal stromal tumor, lymphoma, and leiomyosarcoma. Given that malignancy was suspected, she underwent exploratory laparotomy. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Exploratory laparotomy identified the tumor about 40 cm from the lower region of the ligament of Treitz. The specimen revealed a solid homogenous tumor mass measured 9.2 cm × 5.9 cm × 4 cm in the lower abdomen with an invasion of the ileum [ Figure 1b ].
Under the histological examination of the tumor, hypercellular monomorphic small blue round cells with scant cytoplasm and focal clearing of the cytoplasm were arranged in sheets and compact nest patterns microscopically [ Figure 2a ]. The tumor cells lacked well-formed rosettes. The round-to-oval nuclei had finely distributed chromatin and a small nucleolus [ Figure 2b ]. Mitotic figures were infrequent. Besides, foci of necrosis, hemorrhage, and edema within the tumor were noted. The initial differential diagnoses included small cell carcinoma, lymphoma/leukemia, synovial sarcoma, EWS/PNET, neuroblastoma, alveolar rhabdomyosarcoma, and desmoplastic small round cell tumor.
A panel of immunochemical markers revealed that the tumor cells were positive for vimentin, CD99, FLI1, and NKX2.2 expressed in a membranous fashion for CD99 and showing nuclear reactivity for NKX2.2 [ Figure 3a and b] as well as nuclear reactivity for FLI1 [ Figure 3c ]. Staining for the other markers, including leukocyte common antigen markers and neuroendocrine markers, were all negative. [2, 3] A genetic fluorescence in situ hybridization (FISH) analysis for the EWSR1 gene showed a break-apart signal pattern and revealed a t (11-22) translocation of the tumor cells, indicating a translocation involving the EWS gene [ Figure 4 ]. [4] Adjuvant chemotherapy was suggested; however, Ms. B defaulted for any further treatment, and she was lost to follow-up. cell tumor. EWS/PNET were first documented by Stout in 1918. [5] EWS/PNETs can be classified into two main groups: central EWS/PNET that grow from the central nervous system and peripheral pEWS/PNET that grow somewhere outside the central nervous system. [6] EWS/PNETs are generally identified in children and young adults along the central axis, mostly in the soft tissue or bone. This aggressive and unusual tumor has been seen in the esophagus, liver, pancreas, adrenal gland, kidneys, prostate, urinary bladder, and gynecological organs. [7] To the best of our knowledge, only 36 cases of intestinal EWS/PNET have been previously documented. In summary, the author has collected all previous cases of a published report of intestinal ES/PNET in Table 1 . The small intestine besides the mesentery is the most common location, followed by the mesocolon and duodenum. The current study reveals another rare area, i.e., the ileocecum. [8] Currently, there are no blood markers reported to be helpful for diagnosing EWS/PNET. The histologic manifestation of the tumor typically consists of round-to-ovoid hyperchromatic cells with little cytoplasm, arranged in a solid nest growth pattern with varying rosette-like formations. It is possible to distinguish EWS/PNETs from other small round-cell tumors by immunohistochemical stains and molecular analysis; however, it is hard to differentiate EWS/PNET from other small blue round blue cell tumors. [9] The FISH analysis of EWS/PNET in our case revealed the rearrangement of the EWSR1 gene. Mhawech-Fauceglia et al.
DISCUSSION
EWS/PNET usually occurs in the soft tissues, bones, or central nervous system as a sporadic aggressive malignant small round
proved that a combination of CD99 and FLI1 is the most sensitive and specific test panel for the diagnosis of EWS/PNET. [6] Recently, Yoshida et al. reported that a significant target of EWS-FLI1, the NKX2.2 gene, is a useful marker for EWS/PNET, with a sensitivity of 93% and a specificity of 89%. [3] The genetic feature is the occurrence of a specific translocation, t (11; 22) (q24; q12), revealed in 90%-95% of patients, which is critical for an accurate diagnosis, selection of the most favorable treatment, and prognosis. [2, 4, 10] Currently, there is no preferred conventional treatment modality for intestinal EWS/PNET. Complete surgical excision provides the greatest chance of survival, and adjuvant radiotherapy may decrease local recurrence. Li et al.'s demographic research has indicated that EWS is far less frequent in Asian than in the United States Caucasian population. Nevertheless, whether the result is associated with genetic background differences still needed to be studied. [7] In conclusion, we have reported for the first time an unusual case of mesenteric localized ES/PNET in the Asian population, as confirmed by histopathologic examination and genetic analyses. The present case, together with previous studies, has expanded the spectrum of the tumor in the small intestine and the absence of metastasis of this patient is the critical fact in the Ms. B's prognosis. 
INTRODUCTION
Primitive neuroectodermal tumor (PNET) of the kidney is extremely rare entity, and less than 100 cases have been reported in literature. [1, 2] PNET is a malignant small round cell tumor that has the neural crest regarded as the most likely progenitor. [3] PNET most commonly occurs in bones and is equivalent to Ewing's sarcoma microscopically, immunohistochemically, and genetically. [4] 
CASE REPORT
A 45-year-old male admitted to our hospital in urosurgery unit with complaints of fever, pain in the abdomen, and hematuria for 15 days. He had a history of intermittent pain in the abdomen for 6 months. There was no contributory significant family or past history. Ultrasonography of the abdomen and pelvis revealed large solid and cystic right renal mass measuring 16 cm × 10 cm × 3 cm. There was no evidence of any metastasis. Urine analysis showed mild proteinuria, hematuria, and pus cells. Other investigations were normal. Right nephrectomy was done. On gross examination, we received right nephrectomy specimen totally measuring 20 cm × 10 × cm 5 cm with large mass at the upper half of the right kidney 15 cm × 13 cm × 3.5 cm. Cut section showed solid grayish-brown tumor with fleshy areas and large cystic cavity filled with necrotic material and blood [ Figure 1 ]. Pelvic, ureter, and renal vessels were unremarkable. Perinephric fat was adherent to underlying kidney. Three lymph nodes were noted, largest measuring 0.5 cm in diameter. On microscopy showed highly cellular tumor consists of malignant small round cells arranged in cohesive sheets, lobules, nest, rosettes separated by thin fibrous bands [ Figure 2 ].Homer Wright pseudorosettes were present. Predominantly, perivascular arrangement was noted [ Figure 3 ]. Tumor showed extensive areas of hemorrhage, cyst formation, and necrosis. Tumor does not show any tubule or glomeruloid formation. High mitotic activity was noted. Tumor with oval or spindle cells was noted. Tumor infiltrating the capsule, perinephric fat, pelvis, and lymph nodes was noted [ Figure 4 ].On histopathology reported as malignant small blue round cell tumor suggestive of primary PNET right renal mass.The immunohistochemical study was done. On immunohistochemistry, tumor showed diffuse membrane positivity for CD99 (MIC-2 gene product) and immunonegativity for creatine kinase, neuron-specific enolase (NSE), leukocyte common antigen (LCA), and desmin. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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DISCUSSION
Renal PNET is extremely rare tumor and considered as Ewing's sarcoma family-related group having monotonous small round cells. It is characterized by a translocation resulting in a fusion of the EWS gene and ETS-related family of oncogenes.
PNET is a malignant small round cell tumor and typically arises from the bone or soft tissue in the trunk or axial skeleton in adolescent and young adults. Various other primary sites are pelvis, retroperitoneum, limbs, neck, and paraspinal region. PNETs as primary genitourinary system have been reported rarely in the kidney, bladder, and prostate. [5, 6] Renal PNET clinically shows nonspecific clinical features such as vague abdominal pain, lump in groin, fever, weight loss, and fever with hematuria. Many cases with aggressive clinical course with metastatic disease stage and poor prognosis have been reported. Many cases may show rapid progression with death within 1 year.
Our patient underwent nephrectomy which showed large tumor mass measuring 15 cm × 13 cm × 3.5 cm. Reported cases showed more than 10 cm mass in 65% of cases. [6] Histopathology showed features of malignant round cell tumor with extensive cystic change, necrosis, and hemorrhage. The differential diagnosis for renal PNET includes other small round cell tumors such as adult nephroblastoma, carcinoid, neuroblastoma, clear cell sarcoma of the kidney, lymphoma, small cell variant of osteosarcoma, desmoplastic round cell tumor, and malignant rhabdomyosarcoma. [7, 8] For better confirmatory diagnosis, immunohistochemistry analysis is necessary. In our case, tumor cells express MIC-2 gene product CD99 and were immunonegative for cytokeratin, LCA, desmin, and synaptophysin.
PNET is immunoreactive to CD99 and is clue for the diagnosis. For other malignant round cell tumors, cytokeratin (for nephroblastoma, small cell carcinoma, and synovial sarcoma), LCA (for lymphoma), and NSE/chromogranin (for neuroblastoma) will be helpful for differentiation from PNET.
Moreover, cytogenetic studies demonstrated that PNET and Ewing's sarcoma are analogous to a translocation of the long arm of the chromosome t (11;22)(q24;q12) [8] .
As the PNET is highly aggressive, it is often diagnosis in advance stage. The 5-year disease-free survival rate is 45%-55% in early disease cause while only 2 years for advance stage. [9] The treatment modalities include surgery with early and aggressive chemotherapy.
CONCLUSION
Renal PNET is a rare entity. It should be differentiated from other primary renal malignancies. The differentiation of the malignant small round cell tumors may be challenging; however, it is essential for better management of the patient.
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INTRODUCTION
The association of Epstein-Barr virus (EBV) and B-cell lymphoproliferative disorders (LPDs) is well established. After primary infection at an early stage, EBV persistently infects B-cells in majority of adults, thereby eliciting transformation and multiplication through a variety of complex mechanisms such as the nuclear factor kappa B pathway. [1, 2] Normally, the EBV-induced B-cell proliferation is counterbalanced by immunologic interactions, thus maintaining the EBV-infected cells at a low level. [3] Immunosuppression (IS) with a wide array of agents affects immune surveillance and homeostasis, thus permitting emergence of EBV-LPD. Immunosenescence has also been recently described to be associated with EBV-LPDs. [4] We report a case of a 59-year-old female who developed a mucocutaneous ulcer (MCU) associated with IS, the first case report of EBV-associated MCU from India to the best of our knowledge.
CASE REPORT
A 59-year-old female presented with an ulcer in the inner aspect of her right cheek associated with pain and difficulty in speaking for 2 months. She was a known case of rheumatoid arthritis on methotrexate (MTX) for 15 years. There was no history of trauma, smoking, or tobacco consumption. Clinical examination revealed an infiltrative lesion on the right buccal mucosa involving the lower gingivobuccal sulcus of size 2 cm × 3 cm extending to the alveolus. Regions 46 and 47 appeared indurated with palpable lymph nodes involving the right side of region IB. Systemic examinations were within normal limits. The clinical impression was of carcinoma buccal mucosa. Investigations revealed a normal hemogram; viral markers were negative. Liver and renal functions were normal. Anti-EBV-CA-IgM and qualitative This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Case Report
The diagnostic morphologic features include (i) well-circumscribed and superficial lesion surrounded by prominent rim of small T-lymphocytes at the base. (ii) Subepithelial infiltrates containing pleomorphic blasts that may be reminiscent of RS cells admixed with a polymorphous infiltrate, eosinophils being prominent sometimes. (iii) The blasts are of B-cell origin with concomitant positivity for CD30, CD45, and EBV in most cases. CD20 is negative in approximately 11.5% of cases, focal/weak staining in approximately 19%. [4] CD15 positivity may be noted, thus mimicking a diagnosis of CHL. In this case, the blasts were positive for CD30 and EBV-LMP1 and focally positive for CD20 and CD79a. (iv) The infiltrate is also known to contain abundant CD8-positive T-cells and large numbers of EBV-positive plasmacytoid apoptotic cells, not common to CHL. Thus, the presence of abundant apoptosis rules out the diagnosis of EBV-associated CHL, its presence being suggestive of preserved normal control mechanisms and lack of a transformed phenotype. [4, 6] In EBV-LPDs associated with MTX, the lack of expression of CD15 in CD30-positive Hodgkin/Reed-Sternberg (HRS)-like cells rules out CHL. [7] An additional parameter not typical for CHL is the wide range in cell size of the EBV-positive cells as highlighted by CD20, CD30, and EBV-encoded RNA. Typically, these cells include some small lymphocytes, immunoblasts, and large HRS-like cells which unlike CHL are CD45 positive. [4] In addition, the CD15-positive cells in CHL do not harbor Oct-2 and Bob-1. A uniform positivity for EBV-LMP1 on immunohistochemistry in a spectrum of cells rules out CHL with an underlying history of MTX-induced IS. The presentation of EBVMCU as an isolated ulcerating lesion without a tumor mass and no systemic involvement rules out the diagnosis of an aggressive posttransplant LPD. [8] As far as the mechanism of action for MTX is concerned for EBVMCU, MTX directly induces EBV replication by activation Gross examination showed mucosa-covered tissue measuring 0.3 cm × 0.2 cm × 0.1 cm.
Microscopy revealed buccal mucosa with ulceration and acute inflammatory exudate. The subepithelial stroma was infiltrated by numerous medium-to-large lymphoid cells with focal angiocentricity displaying enlarged vesicular nuclei, prominent nucleoli, and eosinophilic cytoplasm. Few binucleate cells were present, but classical RS cells were not seen. Admixed were few histiocytes, immunoblasts, and eosinophils. On immunohistochemistry, the neoplastic lymphoid cells were CD30 and EBV-LMP1 positive. CD20 and CD79a were strongly positive in 30% of cells, many being perivascular. The Ki-67-labeling index was 60%. Pan-cytokeratin, CD56, CD3, CD138, CD15, and anaplastic lymphoma kinase-1 were negative [ Figures 1 and 2 ].
In view of the history of MTX-induced IS, histology, and supporting immunohistochemistry, a diagnosis consistent with EBV-positive MCU (EBVMCU) was made.
IS was discontinued, and the patient was started on metronidazole leading to healing of the ulcer.
DISCUSSION
Dojcinov et al. first reported the entity EBVMCU in 26 patients, 9 associated with IS caused by MTX, azathioprine, and cyclosporine-A given for autoimmune diseases and 17 with ulceration of the skin or mucosa with no systemic involvement as evident in this case. [4, 5] EBVMCU is an entity associated with IS from a variety of origins, suggesting a common pathogenetic mechanism. The lesion is characterized by an isolated and circumscribed cutaneous and mucosal presentation with an indolent behavior and a self-limited clinical course being thought to have resulted from a minimal and localized lapse in immunosurveillance over EBV. The morphologic and immunophenotypic features at times may be mistaken for classical Hodgkin lymphoma (CHL) due to the overlap with CD15 positivity and CD20. [4] of early viral promoters. [9] Most cases diagnosed with EBVMCU on IS have regressed on withdrawal of the drug. [4] Another close differential is lymphomatoid granulomatosis; however, the lack of pulmonary involvement, strong CD30 positivity, and downregulation of CD20 argues against the diagnosis. CD30+ LPD of the oral cavity is also a differential; however, these tumors are typically negative for EBV-LMP1 and CD20 and positive for T-cell markers. [10] CONCLUSIONS EBVMCU is a unique entity that must be considered as a differential diagnosis of in a case presenting with mucosal ulceration. Differentiation from aggressive lymphoma which is a histologic mimic is essential because EBVMCU due to IS can resolve on withdrawal of immunosuppressive agents.
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INTRODUCTION
Urothelial carcinoma (UC) of urinary bladder is notorious to show divergent differentiation along squamous, small cell, glandular, trophoblastic, and even rhabdoid cell lines. [1, 2] However, rhabdomyosarcomatous differentiation in adult urinary bladder carcinoma is uncommon. This differentiation may be demonstrated in bladder as pure rhabdomyosarcoma (RMS) or as a component of sarcomatoid UC (SUC) with an aggressive course. [1] We discuss a rare case of UC of urinary bladder with an occult heterologous component of ERMS which is seen at the metastatic site as an exclusive component.
CASE REPORT
A 74-year-old male was investigated for bouts of hematuria over a month. He was a known hypertensive, controlled on medication. He was also an alcoholic and a chronic smoker. The patient had no significant past or family history. A contrast-enhanced computed tomography (CT) scan of abdomen was done which revealed urinary bladder wall thickening involving anterior wall, posterior wall, and dome measuring 5 cm × 4.8 cm × 4.8 cm. Overlying abdominal wall showed a growth measuring 4.8 cm × 4.1 × 3 cm. Findings were suggestive of malignant growth of urinary bladder with enterovesical fistula and anterior abdominal wall metastasis. Positron emission tomography CT did not reveal any other fludeoxyglucose avid lesion elsewhere in the body other than abdominal wall. Bladder biopsy was diagnostic of invasive UC, high grade with muscle invasion and extensive areas of necrosis. An exploratory laparotomy with partial cystectomy and segmental ileal resection with ileo-ileal anastomosis with double-barreled ileostomy was performed along with wide local excision of the abdominal wall metastasis.
On examination, partial cystectomy specimen measured 13.5 cm × 10 cm × 4 cm. Bladder wall was involved by an ulcero-infiltrative firm white growth. Segment of small intestine measured 40 cm, sent separately, showed multiple exudate covered areas with tumor deposits in the wall. Abdominal wall deposit measured 5 cm × 4 cm × 3 cm. Microscopic examination from cystectomy specimen showed invasive UC, high grade with infiltration into perivesical fat. UC in situ, extensive areas of necrosis and lymphovascular emboli were also evident. Extensive sampling was done and no heterologous elements were seen. The tumor cells expressed P63, 34 βE12, and GATA3 [ Figure 1 ]. Sections from ileal loop showed multiple tumor 
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deposits throughout the wall with invasion into small bowel mucosa with similar histomorphology and IHC profile. Sections from anterior abdominal wall growth revealed diffuse sheet-like proliferation of cells having rhabdoid/epithelioid morphology displaying vesicular nuclei, single prominent nucleoli and inclusion like dense eosinophilic cytoplasm. Areas of necrosis along with brisk mitosis (3-4/hpf) were noted. No urothelial component was evident on extensive sampling. These tumor cells were negative for pan-CK, P63, 34 βE12, synaptophysin, and GATA-3. However, they expressed desmin, myogenin, and MyoD1 [ Figure 2 ]. A p53 immunostain revealed strong, intense, and diffuse nuclear expression at the primary and metastatic abdominal wall site [ Figure 3 ]. Overall histomorphological features in conjunction with IHC, was diagnostic of invasive UC, high grade of UB with only heterologous component de-differentiation (RMS; epithelioid type) at the metastatic abdominal site. The patient was advised neoadjuvant chemotherapy; however, he refused any further medical intervention and was subsequently lost to follow-up.
DISCUSSION
SUC is a rare entity, accounting for only 0.6% of all bladder tumors diagnosed. Radiation and cyclophosphamide therapy increases the risk of sarcomatoid differentiation. [1] These lesions are usually characterized by a predominant carcinoma component. The common sarcomatous elements seen are condrosarcomas, leiomyosarcoma, and malignant fibrous histiocytoma. [3] Metastases of SUC usually has a mixed histology, with epithelial predominance.
In the present case, despite extensive sampling, no heterologous element could be demonstrated in the primary bladder tumor. Possibly, an occult microscopic focus of de-differentiation amounts to this explanation which could not be recognized. A case on similar lines was recently reported by Cuadra-Urteaga et al., [4] who were able to demonstrate a single microscopic focus of angiosarcoma in UC of the upper urinary tract that had extensively metastasized. Smith et al. [5] also reported two cases of histomorphological disparity at the primary metastatic site. One of their cases of UC had only sarcomatous component at metastatic site while the second case had displayed an isolated carcinomatous component at the metastatic site in an otherwise sarcoma of urinary bladder.
The histogenesis of SUC has been a matter of much discussion; however, several studies have lent support to the divergence hypothesis which contends that a single cancer stem cell gives rise to the morphologically dissimilar epithelial and mesenchymal components. [4, 6] Interestingly, in our case, we found an oligometastasis of RMS which in itself is uncommon in adults. [7] Attributing RMS as a second primary in this elderly age group at the anterior abdominal wall is highly unlikely. As UC with rhabdoid differentiation [2, 8] and rhabdomyosarcomatous differentiation [7] is a known entity, it is a more proffered explanation of the abdominal wall nodule in the current case. The common monoclonal origin of tumor cells at both sites is further supported by a similar strong, intense, and diffuse p53 expression at the primary and metastatic site. This finding is strongly supported by the results of Armstrong et al., [6] who provided evidence of a common clonal origin between the phenotypically The metastatic site RMS in the present study showed diffuse sheet-like growth of tumor cells having relatively uniform cytomorphologic features; suggestive of epithelioid RMS. Epithelioid RMS is a newly described entity with only a handful of reports published till date. Zin et al. [9] reported five cases epithelioid RMS in pediatric age group with a median age of 8.8 years. In their retrospective study, the patients had been diagnosed as alveolar RMS variants previously and treated accordingly. Jo et al. [10] reviewed RMS cases reported over 18 years and re-reported 16 patients with EpiRMS. The median patient age in their study was 70.5 years. All of the reported EpiRMS cases lacked PAX3/7 FOXO1 fusion transcripts; however, no specific rearrangement has been persistently associated with this neoplasm, thus making it a distinct entity. Molecular profiling was not done in the present case; however, it adds onto the existing datasheet in terms tumor presentation and tumor site. The recognition of epithelioid RMS as a distinct entity can impact patient management by guiding appropriate oncologic treatment modalities specific for RMS.
In the present case, RMS being an aggressive tumor led to rapid tumor evolution and metastasis to abdominal wall. However, IHC is imperative to distinguish epithelioid RMS from UC with rhabdoid differentiation. Epithelioid RMS cells express myogenin and myoD1 while they are negative for pan-CK. On the contrary, UC cells with rhabdoid differentiation express pan-CK while they are negative for markers of skeletal muscle differentiation. The recommended standard guidelines are but well established for carcinosarcoma, and majority of the cases show aggressive clinical course. The present case describes rarity of an occult heterologous sarcomatous component as an exclusive metastasizing component. Judicious IHC panel can differentiate UC with rhabdoid differentiation from heterologous RMS component.
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